Patent number: 11395870
Abstract: Embodiments of negative pressure wound therapy systems, apparatuses, and methods for operating the systems and apparatuses are disclosed. In some embodiments, the apparatus includes a negative pressure source, a connector port, at least one switch, and a controller. The negative pressure source is connected through the connector port to either (i) a wound dressing having a canister configured to store fluid aspirated from the wound or (ii) a wound dressing without a canister between the connector port and the wound dressing. The controller determines, based on a signal received from the at least one switch, whether the canister is positioned in the fluid flow path and adjusts one or more operational parameters of negative pressure wound therapy based on the determination. The switch is activated by the connection of either the canister or canisterless wound dressing to the apparatus.
Type:
Grant
Filed:
February 15, 2018
Date of Patent:
July 26, 2022
Assignee:
Smith & Nephew Asia Pacific Pte. Limited
Inventors:
Ben Alan Askem, Anthony Jonathan Bedford, Kevin Bendele, Ali Khishdoost Borazjani, Nicola Brandolini, Ian Charles Culverhouse, Otteh Edubio, James Maxwell Eelbeck, Matt Ekman, Matthew Keith Fordham, Philip Gowans, Michael James Hayers, Mark Richard Hesketh, James Daniel Homes, Allan Kenneth Frazer Grugeon Hunt, Mark Edward Jones, William Kelbie, Reece Knight, David Mcleod, Nisha Mistry, Samuel John Mortimer, Fatoona Mosa, Matthew Murphy, Michael Paton, Neil Harry Patrick, Louis della-Porta, Felix Clarence Quintanar, Lee Michael Rush, Carl Dean Saxby, Hannah Bailey Sidebottom, Daniel Lee Steward, Catherine Thaddeus, Simon Tyson, David Ronald Upton, William Jacob Ward, Nicholas Warrington
Publication number: 20210388066
Abstract: Antibodies that bind SARS-CoV spike protein, SARS-CoV-2 spike protein, and methods of using same for treating or preventing conditions associated with SARS or COVID-19 and for detecting SARS-CoV or SARS-CoV-2.
Type:
Application
Filed:
June 22, 2021
Publication date:
December 16, 2021
Applicants:
AbCellera Biologics Inc., The United States of America, as represented by the Secretary, Department of Health and Human Svcs.
Inventors:
Kathryn WESTENDORF, Stefanie ZENTELIS, Krithika MUTHURAMAN, Kevin JEPSON, Ester FALCONER, John MASCOLA, Barney GRAHAM, Kizzmekia CORBETT, Julie LEDGERWOOD, Lingshu WANG, Olubukola ABIONA, Wei SHI, Wing-pui KONG, Yi ZHANG, Bryan Edward JONES, Denisa FOSTER, Julian DAVIES, Qing CHAI, Christopher Carl FRYE, Ganapathy GOPALRATHNAM, Jörg HENDLE, John Michael SAUDER, Jeffrey Streetman BOYLES, Anna PUSTILNIK
Publication number: 20210292393
Abstract: Antibodies that bind SARS-CoV spike protein, SARS-CoV-2 spike protein, and methods of using same for treating or preventing conditions associated with SARS or COVID-19 and for detecting SARS-CoV or SARS-CoV-2.
Type:
Application
Filed:
December 9, 2020
Publication date:
September 23, 2021
Applicants:
AbCellera Biologics Inc., The United States of America, as represented by the Secretary, Department of Health and Hunman Servi
Inventors:
Kathryn WESTENDORF, Stefanie ZENTELIS, Krithika MUTHURAMAN, Kevin JEPSON, Ester FALCONER, John MASCOLA, Barney GRAHAM, Kizzmekia CORBETT, Julie LEDGERWOOD, Lingshu WANG, Olubukola ABIONA, Wei SHI, Wing-pui KONG, Yi ZHANG, Bryan Edward JONES, Denisa FOSTER, Julian DAVIES, Qing CHAI, Christopher Carl FRYE, Ganapathy GOPALRATHNAM, Jörg HENDLE, John Michael SAUDER, Jeffrey Streetman BOYLES, Anna PUSTILNIK